RIL
TNXP icon

Rothschild Investment LLC’s Tonix Pharmaceuticals TNXP Stock Holding History

Rothschild Investment LLC’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.81K Buy
299
+213
+248% +$2.75K ﹤0.01% 2428
2026
Q1 		$1.18K Buy
86
+85
+8,500% +$1.31K ﹤0.01% 2798
2025
Q4 		$16 Buy
+1
New +$18 ﹤0.01% 3353

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rothschild Investment LLC's TNXP Position: Q2 2026 in Review

Rothschild Investment LLC increased its Tonix Pharmaceuticals (TNXP) stake by 248% in Q2 2026, buying an estimated $2.75K and bringing the position to 299 shares worth $3.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2428.

Rothschild Investment LLC first reported a position in TNXP in Q4 2025 and has held it in 3 quarters since. 102 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Rothschild Investment LLC held 299 shares of Tonix Pharmaceuticals worth $3.81K as of Q2 2026.
  • Rothschild Investment LLC bought 213 Tonix Pharmaceuticals shares in Q2 2026, an estimated $2.75K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2428 holding.
  • Rothschild Investment LLC first reported a position in Tonix Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 102 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.